AU757556B2 - Polymorphic CAG repeat-containing gene and uses thereof - Google Patents

Polymorphic CAG repeat-containing gene and uses thereof Download PDF

Info

Publication number
AU757556B2
AU757556B2 AU91495/98A AU9149598A AU757556B2 AU 757556 B2 AU757556 B2 AU 757556B2 AU 91495/98 A AU91495/98 A AU 91495/98A AU 9149598 A AU9149598 A AU 9149598A AU 757556 B2 AU757556 B2 AU 757556B2
Authority
AU
Australia
Prior art keywords
pro
ser
leu
ala
gly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU91495/98A
Other languages
English (en)
Other versions
AU9149598A (en
Inventor
Chawki Benkelfat
Ridha Joober
Guy A. Rouleau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
McGill University
Original Assignee
McGill University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by McGill University filed Critical McGill University
Publication of AU9149598A publication Critical patent/AU9149598A/en
Application granted granted Critical
Publication of AU757556B2 publication Critical patent/AU757556B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU91495/98A 1997-09-19 1998-09-18 Polymorphic CAG repeat-containing gene and uses thereof Ceased AU757556B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA 2216057 CA2216057A1 (en) 1997-09-19 1997-09-19 Polymorphic cag repeat-containing gene, diagnosis of psychiatric diseases and therapeutic uses thereof
CA2216057 1997-09-19
PCT/CA1998/000884 WO1999015639A1 (en) 1997-09-19 1998-09-18 Polymorphic cag repeat-containing gene and uses thereof

Publications (2)

Publication Number Publication Date
AU9149598A AU9149598A (en) 1999-04-12
AU757556B2 true AU757556B2 (en) 2003-02-27

Family

ID=4161505

Family Applications (1)

Application Number Title Priority Date Filing Date
AU91495/98A Ceased AU757556B2 (en) 1997-09-19 1998-09-18 Polymorphic CAG repeat-containing gene and uses thereof

Country Status (6)

Country Link
EP (1) EP1015574A1 (ja)
JP (1) JP2001517432A (ja)
AU (1) AU757556B2 (ja)
BR (1) BR9812254A (ja)
CA (1) CA2216057A1 (ja)
WO (1) WO1999015639A1 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19835910C1 (de) * 1998-08-07 2000-05-04 Deutsches Krebsforsch Gen isoliert auf dem kurzen Arm des menschlichen Chromosoms 17
PL366083A1 (en) * 2000-09-08 2005-01-24 Iowa State University Research Foundation, Inc. Novel prkag3 alleles and use of the same as genetic markers for reproductive and meat quality traits
GB0228079D0 (en) * 2002-12-02 2003-01-08 Laxdale Ltd Huntington's Disease
WO2008032056A2 (en) * 2006-09-16 2008-03-20 Genophrenix Limited Dopamine receptor interacting proteins as markers for disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834183A (en) * 1993-06-29 1998-11-10 Regents Of The University Of Minnesota Gene sequence for spinocerebellar ataxia type 1 and method for diagnosis
WO1997018825A1 (en) * 1995-11-17 1997-05-29 The University Of British Columbia PROTEIN WHICH INTERACTS WITH THE HUNTINGTON'S DISEASE GENE PRODUCT, cDNA CODING THEREFOR, AND ANTIBODIES THERETO

Also Published As

Publication number Publication date
JP2001517432A (ja) 2001-10-09
AU9149598A (en) 1999-04-12
EP1015574A1 (en) 2000-07-05
CA2216057A1 (en) 1999-03-19
WO1999015639A1 (en) 1999-04-01
BR9812254A (pt) 2002-07-09

Similar Documents

Publication Publication Date Title
Billett et al. Obsessive compulsive disorder, response to serotonin reuptake inhibitors and the serotonin transporter gene
Michelon et al. Association study of the INPP1, 5HTT, BDNF, AP-2β and GSK-3β GENE variants and restrospectively scored response to lithium prophylaxis in bipolar disorder
Sander et al. Serotonin transporter gene variants in alcohol-dependent subjects with dissocial personality disorder
Wishart et al. COMT Val158Met genotype and individual differences in executive function in healthy adults
Aoki-Suzuki et al. A family-based association study and gene expression analyses of netrin-G1 and-G2 genes in schizophrenia
Lappalainen et al. Association between alcoholism and γ‐amino butyric acid α2 receptor subtype in a Russian population
Funke et al. COMT genetic variation confers risk for psychotic and affective disorders: a case control study
Domschke Clinical and molecular genetics of psychotic depression
Weber et al. The genetic contribution of the NO system at the glutamatergic post-synapse to schizophrenia: further evidence and meta-analysis
Kukshal et al. Association study of neuregulin-1 gene polymorphisms in a North Indian schizophrenia sample
Joober et al. DRD3 and DAT1 genes in schizophrenia: an association study
Hattori et al. Identification of a compound short tandem repeat stretch in the 5′-upstream region of the cholecystokinin gene, and its association with panic disorder but not with schizophrenia
Tybura et al. Pharmacogenetics of adverse events in schizophrenia treatment: comparison study of ziprasidone, olanzapine and perazine
Mahieu et al. No association between bipolar affective disorder and a serotonin receptor (5-HT2A) polymorphism
JP2020089370A (ja) 抗精神病薬に基づく処置により誘導される錐体外路症状（ｅｐｓ）の発症を予測する方法
Ehret et al. Microdeletions in 9q33. 3-q34. 11 in five patients with intellectual disability, microcephaly, and seizures of incomplete penetrance: is STXBP1 not the only causative gene?
Giri et al. Genetic screening of THAP1 in primary dystonia patients of India
Deckert et al. Human adenosine A 2a receptor (A 2a AR) gene: systematic mutation screening in patients with schizophrenia
Rothe et al. Association study of serotonin-2A receptor gene polymorphism and panic disorder in patients from Canada and Germany
Borroni et al. Haplotypes in cathechol-O-methyltransferase gene confer increased risk for psychosis in Alzheimer disease
AU757556B2 (en) Polymorphic CAG repeat-containing gene and uses thereof
Oswald et al. Lack of association between the 5HT2A receptor polymorphism (T102C) and unipolar affective disorder in a multicentric European study
Karam et al. Catechol-O-methyltransferase Val158Met polymorphism and hyperactivity symptoms in Egyptian children with autism spectrum disorder
Kennerson et al. X-linked distal hereditary motor neuropathy maps to the DSMAX locus on chromosome Xq13. 1-q21
Heary et al. Genetics of scoliosis

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired